The World Health Organization (WHO) has released a significant new guideline advising against the use of non-sugar sweeteners (NSS), commonly known as artificial or low-calorie sweeteners, for controlling body weight or reducing the risk of noncommunicable diseases. This comprehensive recommendation, published following an extensive review of scientific evidence, challenges the long-held perception of NSS as a healthy alternative to sugar. The organization’s analysis suggests that while NSS may offer a temporary reduction in calorie intake when replacing sugar, they do not appear to promote long-term weight loss in adults and children and are associated with potential adverse health outcomes.
The WHO’s guideline, which encompasses a broad range of NSS including acesulfame K, aspartame, saccharin, sucralose, and stevia, is the culmination of a systematic review of available research. The review considered evidence from various study designs, including randomized controlled trials and observational cohort studies, to form its recommendations. Notably, the analysis excluded sugar alcohols like maltitol, xylitol, and sorbitol, which are also frequently used as sugar substitutes in food and beverage products.
Challenging the Weight Loss Promise
A central finding of the WHO’s review is the lack of evidence supporting the efficacy of NSS for long-term weight management. The organization concluded that replacing sugar with NSS did not result in sustained weight loss in either adults or children. While some short-term clinical trials indicated that higher NSS consumption led to a reduction in calorie intake when these sweeteners substituted sugar or sugar-sweetened products, this effect did not translate into significant long-term weight reduction. Furthermore, the impact of NSS on hunger and satiety levels proved inconsistent. Some studies reported reduced hunger, while others observed a stronger appetite among participants consuming higher quantities of NSS-containing beverages. This ambiguity highlights the complex physiological responses to NSS and underscores the need for further investigation into their effects on appetite regulation.
Potential Links to Chronic Diseases
Beyond weight management, the WHO guideline raises concerns about the potential association between NSS consumption and an increased risk of certain noncommunicable diseases. Observational cohort studies reviewed by the organization suggested a link between the long-term consumption of NSS-containing beverages and a heightened risk of cardiovascular disease and premature death in adults. Similarly, higher intake of NSS, whether added to food or beverages, was associated with an increased likelihood of developing type 2 diabetes.
However, the WHO acknowledges a critical caveat in interpreting these observational findings: the potential for "reverse causation." This phenomenon suggests that individuals who are already predisposed to chronic diseases, such as those with higher body mass index, obesity, or metabolic risk factors, might be more likely to opt for NSS as a perceived health-conscious choice. Therefore, the observed association might reflect pre-existing health conditions rather than NSS directly causing these diseases. The WHO’s review found no significant association between NSS intake and cancer or cancer-related deaths.
A Call for Dietary Sweetness Reduction
Based on these findings, the WHO’s overarching recommendation is for individuals to actively reduce the overall sweetness in their diets, emphasizing that this dietary shift should ideally begin early in life. The organization stresses that NSS offer no nutritional value and therefore do not contribute to a healthy diet. This recommendation encourages a broader re-evaluation of dietary habits, moving away from reliance on intense sweetness, whether from sugar or NSS, towards a more nuanced appreciation of natural flavors.
Expert Perspectives and Criticisms
The WHO’s guideline has generated considerable discussion within the scientific community. Experts from the Harvard T.H. Chan School of Public Health, while largely concurring with the WHO’s call to reduce overall sweetness in the diet, have also raised important criticisms regarding the methodology of the WHO’s meta-analysis. Specifically, they point to the exclusion of several large cohort studies that involved over 100,000 participants. These omitted studies reportedly found that increasing the consumption of artificially sweetened beverages at the expense of sugar-sweetened beverages was associated with less weight gain over time. This finding aligns with the outcomes observed in smaller, short-term randomized controlled trials.
Based on statistical modeling from these excluded studies, it was estimated that replacing one serving of a sugar-sweetened beverage with an artificially sweetened beverage could be linked to a 4% lower risk of total mortality, a 5% lower risk of cardiovascular disease-related mortality, and a 4% lower risk of cancer-related mortality. This perspective suggests that for individuals who habitually consume sugar-sweetened beverages, NSS might serve as a beneficial short-term transitional tool.
Optimal Beverage Choices for Long-Term Health
Frank Hu, Chair of the Department of Nutrition at the Harvard T.H. Chan School of Public Health, offered a pragmatic view on beverage choices. He stated, "for habitual consumers of sugar-sweetened beverages, artificially sweetened beverages can be used as a temporary replacement, although the best choices would be water and unsweetened coffee or tea." This perspective highlights the hierarchy of healthy beverage options, with plain water, unsweetened coffee, and tea remaining the gold standard for long-term health and hydration.
The Case of Aspartame: A Closer Look
The recent release of a risk assessment for aspartame by the International Agency for Research on Cancer (IARC), the WHO, and the Joint Expert Committee on Food Additives (JECFA) has further intensified the scrutiny on NSS. Aspartame was classified as a Group 2B carcinogen, meaning there is "limited evidence" of its carcinogenicity in humans, specifically in relation to liver cancer. Despite this classification, the acceptable daily intake (ADI) of aspartame remained unchanged at 40 mg/kg of body weight. The committees noted that their review did not present evidence that warranted altering this guideline, affirming that intake within this range is safe. For an average adult, this translates to a daily limit of approximately 2,727 mg of aspartame, equivalent to about eleven 12-ounce cans of diet soda, each containing roughly 250 mg of aspartame.
The assessment concluded that the evidence regarding cancer risk in humans, based on both animal and human studies, was not convincing. The agencies emphasized the need for more extensive research, particularly longer-term studies with comprehensive follow-up and well-designed randomized controlled trials, to provide more definitive conclusions.
Broader Implications and Future Directions
The WHO’s guideline represents a significant shift in the public health discourse surrounding non-sugar sweeteners. By advising against their use for weight control and disease prevention, the organization is prompting a re-evaluation of dietary strategies aimed at improving public health. This recommendation could influence regulatory policies, food industry practices, and consumer choices worldwide.
The debate surrounding NSS underscores the complexity of nutritional science and the challenges in establishing definitive causal links between dietary components and health outcomes. While observational studies can identify associations, they are often limited by confounding factors and the potential for reverse causation, as highlighted by the WHO. Randomized controlled trials, while offering stronger evidence for causality, are often short-term and may not fully capture the long-term effects of chronic exposure.
Moving forward, a greater emphasis on reducing overall dietary sweetness, prioritizing whole, unprocessed foods, and embracing water as the primary beverage of choice appear to be the most robust strategies for promoting long-term health and well-being. The ongoing research into NSS, particularly long-term studies, will be crucial in further clarifying their roles and potential risks in a balanced diet. The WHO’s guideline serves as a critical call to action, encouraging a more holistic approach to diet and health that prioritizes nutritional value and sustainable lifestyle choices over quick fixes or perceived shortcuts. The implications of this guideline are far-reaching, potentially reshaping how we approach food labeling, public health messaging, and individual dietary decisions in the years to come.